CARLSBAD, Calif.–(BUSINESS WIRE)–Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the pricing of its initial public offering of 6,700,000 shares of common stock at an initial price…
According to filings with the U.S. Securities and Exchange Commission, Carlsmed is raising up to $52,499,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Cordonnier played a key…
La Jolla, CA – According to filings with the U.S. Securities and Exchange Commission, Carlsmed is raising $12,643,855.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Cordonnier played a…